For the Inventor, By the Inventor

Enter assignee name

Middlesex, United Kingdom

Viiv Healthcare UK (no.5) Limited

USPTO Granted Patents = 42

Forward Citations = 9

Loading Chart...

Loading Chart...

66 inventors (with patents filed for the assignee):

B Narasimhulu Naidu (23 out of 54 patents)

John F Kadow (18 out of 136 patents)

Manoj Patel (16 out of 30 patents)

4. Nicholas A Meanwell (13 out of 141 patents)

5. Kevin M Peese (12 out of 22 patents)

6. Tao Wang (8 out of 78 patents)

7. Zhongxing Zhang (8 out of 64 patents)

8. Alicia Regueiro-Ren (7 out of 45 patents)

9. Zhiwei Yin (7 out of 39 patents)

10. Jacob Swidorski (6 out of 24 patents)

11. Makonen Belema (6 out of 53 patents)

12. John A Bender (6 out of 46 patents)

13. Zhongyu Wang (6 out of 14 patents)

14. Sing-Yuen Sit (5 out of 58 patents)

15. Jie Chen (5 out of 29 patents)

42 patents: Sort by Forward Citations

1. 12129255 - Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication (2024-10-29),

2. 11958834 - Inhibitors of human immunodeficiency virus replication (2024-04-16),

3. 11919897 - Inhibitors of human immunodeficiency virus replication (2024-03-05),

4. 11541055 - Inhibitors of human immunodeficiency virus replication (2023-01-03),

5. 11505543 - 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication (2022-11-22),

6. 11155602 - Polypeptides targeting HIV fusion (2021-10-26),

7. 11084845 - C-3 and C-17 modified triterpenoids as HIV-1 inhibitors (2021-08-10),

8. 10954252 - Inhibitors of human immunodeficiency virus replication (2021-03-23),

9. 10577353 - 5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2020-03-03),

10. 10493070 - Azadecalin derivatives as inhibitors of human immunodeficiency virus replication (2019-12-03),

11. 10421774 - C-3 and C-17 modified triterpenoids as HIV-1 inhibitors (2019-09-24),

12. 10407490 - Polypeptides targeting HIV fusion (2019-09-10),

13. 10407410 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-09-10),

14. 10351546 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-07-16),

15. 10221156 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-03-05),

ViiV HEALTHCARE UK (NO.5) LIMITED is a pharmaceutical company specializing in the research, development, and production of innovative treatments for HIV/AIDS. We aim to improve the lives of people living with HIV by providing high-quality medicines, advancing scientific knowledge, and advocating for the needs of the HIV community. With a strong commitment to patient-centered care, we constantly strive to drive positive change in the field of HIV healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

42 Patents

#9 in Middlesex

#403 in United Kingdom

#15,845 in the World

Middlesex, United Kingdom

Viiv Healthcare UK (no.5) Limited

Forward Citations = 9

66 inventors:

B Narasimhulu Naidu (23 out of 54 patents)

John F Kadow (18 out of 136 patents)

Manoj Patel (16 out of 30 patents)

4. Nicholas A Meanwell (13 out of 141 patents)

5. Kevin M Peese (12 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…